Atlas Trials

Assessment of Empagliflozin as Adjuvant Therapy in Patients With Ulcerative Colitis

Clinical trial NCT05058417 · WITHDRAWN

Trial details

NCT number
NCT05058417
Sponsor
Sadat City University
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Ulcerative Colitis
Start date
2021-10-01
Primary completion
2025-09-30
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.